RetinalGenix Technologies (RTGN) Share-based Compensation Growth (1y) (2021 - 2026)
RetinalGenix Technologies (RTGN) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.56% |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -9.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.69% |
| Dec 31, 2025 | -87.60% |
| Sep 30, 2025 | -6.42% |
| Jun 30, 2025 | 18.57% |
| Mar 31, 2025 | -86.62% |
| Dec 31, 2024 | 349.82% |
| Sep 30, 2024 | -30.89% |
| Jun 30, 2024 | 168.77% |
| Mar 31, 2024 | 2,107.18% |
| Dec 31, 2023 | -13.98% |
| Sep 30, 2023 | 506.44% |
| Jun 30, 2023 | 42.61% |
| Mar 31, 2023 | 42.61% |
| Dec 31, 2022 | 965.14% |
| Sep 30, 2022 | 28.41% |
| Jun 30, 2022 | -36.23% |
| Mar 31, 2022 | -50.62% |
| Dec 31, 2021 | -71.47% |